Work with the Trump administration on a review of mifepristone policy.

Roger F. Wicker · Mississippi · Republican

policy impact 0.72 specificity 0.86 extraction confidence 87%

Occurrences

Wicker said he is working with the Trump administration on a review of mifepristone policy

He commits to collaborating on a review of mifepristone policy.

Wicker Promotes Pro-Life Legislation
primary · press_release · model gpt-5.4-mini

Evidence

FDA Commissioner of Food and Drugs Martin Makary committed to conduct a review of mifepristone.

The White House says the FDA commissioner committed to a mifepristone review, confirming the administration-side review was still underway in the lookback window.

partial same_term

Protect Religious Liberty – The White House
secondary · model gpt-5.4-mini · confidence 79%

At the same time, I am working with the Trump administration as it conducts a review of mifepristone policy.

Wicker’s own June 1 statement directly says he is working with the Trump administration on the mifepristone-policy review, which is the strongest candidate-specific evidence available near the lookback window.

partial same_term A for effort

Wicker Promotes Pro-Life Legislation
primary · model gpt-5.4-mini · confidence 93%

Wicker says he is working with the Trump administration while it conducts a review of mifepristone policy.

This is the strongest candidate-specific official evidence in the lookback window and directly matches the commitment.

delivered same_term A for effort

Wicker Promotes Pro-Life Legislation
primary · model gpt-5.4-mini · confidence 97%

The White House page says FDA Commissioner Martin Makary committed to conduct a mifepristone review.

This confirms the administration-side review was still active in the lookback window and supports that Wicker's stated collaboration had a real federal counterpart.

partial same_term A for effort

Protect Religious Liberty – The White House
secondary · model gpt-5.4-mini · confidence 89%

Assessments

delivered same_term

The promise was to work with the Trump administration on a review of mifepristone policy, and Wicker explicitly stated on June 1, 2026 that he was doing exactly that while the administration conducted the review. Separate White House evidence from June 4, 2026 confirms the administration-side review was in fact underway, which supports that his claimed collaboration corresponded to a real federal process. Because the commitment was about participating in the review rather than securing a final policy change, this constitutes delivery in the same term.

provider codex_cli · model gpt-5.4 · confidence 95%

delivered same_term A for effort

Wicker’s own June 1, 2026 statement says he was working with the Trump administration as it conducted a review of mifepristone policy, which directly matches the claim. The White House evidence also confirms the administration-side review was underway in the same period. This is a candidate-specific, in-office action, so it counts as delivered in the same term.

provider codex_cli · model gpt-5.4-mini · confidence 92%